Extra-Ordinary General Meeting of our Company will be held on Wednesday, 7th January, 2026 at 04:00 P.M. through VC/OAAVM to transact the businesses as per the attached Notice of EGM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Limited has called an Extra-Ordinary General Meeting on January 7, 2026 at 4:00 PM via video conferencing to seek shareholder approval for two key items. First, the company plans to increase its authorised share capital from Rs. 10 crore (1 crore equity shares) to Rs. 13.45 crore (1.345 crore shares), which requires amending the Memorandum of Association. Second, the company proposes to issue up to 99,75,000 convertible warrants at Rs. 12.50 each (including a Rs. 2.50 premium) on a preferential basis to non-promoter allottees, raising up to Rs. 12.47 crore. The warrants are proposed to be allotted to three non-promoter entities, including the Managing Director Vishwambar Kameshwar Singh (33 lakh warrants), Vacro Enterprises Private Limited (33.5 lakh), and Qmin Realities Private Limited (33.25 lakh). The proceeds will be used for working capital needs (Rs. 9.35 crore) and general corporate purposes (Rs. 3.12 crore). E-voting window runs from January 4-6, 2026, with the cut-off date set as December 31, 2025.
If approved, the preferential warrant issue could result in dilution of existing shareholders by up to nearly 10% of the current share base on a fully diluted basis. Notably, the Managing Director himself is one of the proposed allottees (listed as non-promoter), which shareholders may view as a signal of insider confidence but should monitor closely for governance reasons.